Day: August 25, 2020
NE PAS DISTRIBUER AUX SERVICES DE FIL DE PRESSE DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNISTORONTO, 25 août 2020 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (la « Société » ou « Doré Copper ») (TSXV: DCMC) est heureuse d’annoncer qu’elle a procédé à la clôture de son placement privé par l’entremise d’un courtier sur la base des « meilleurs efforts », annoncé précédemment (le « Placement »), aux termes duquel la Société a vendu un total de 2 662 072 actions ordinaires du capital de la Société qui seront admissibles à titre d’ « actions accréditives » au sens du paragraphe 66(15) de la Loi de l’impôt sur le revenu (Canada) et, en ce qui concerne les actions ordinaires émises à des résidents du Québec, de l’article 359.1 de la Loi sur les impôts (Québec) (collectivement, les « Actions accréditives »),...
Allegiant Gold Options Historic Mogollon Silver-Gold District to Summa Silver
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“Allegiant” or the “Company”) (AUAU: TSX-V) (AUXXF: OTCQX) is very pleased to announce that it has signed a definitive agreement with Summa Silver (“Summa”) (CSE: SSVR) whereby Summa can acquire up to a 100% interest in the historic Mogollon silver-gold mining district (the “Property”) of southwestern New Mexico from Allegiant Gold Ltd (“Allegiant”) (TSXV: AUAU).Peter Gianulis, CEO of Allegiant Gold, commented: “We are very excited to have reached an agreement with Summa. Their dedication and professionalism throughout this process was unparalleled and we are confident that we selected the right partner to develop one of the best undeveloped silver projects in the U.S. We look forward to their progress and our ability to focus on the development...
Heimavellir hf. – Endurkaup á HEIMA 18.1
Written by Customer Service on . Posted in Public Companies.
Heimavellir hfHeimavellir hafa komist að samkomulagi við Global Macro Absolute Return Advantage Portfolio og Global Macro Portfolio um að Heimavellir hf. kaupi skuldabréfið HEIMA 18.1 af framangreindum sjóðum. Kaupverðið verður greitt með nýju láni og eigið fé. Viðskiptin munu ekki áhrif getu Heimavalla hf. eða dótturfélaga til að standast fjárhagskvaðir annarra skuldabréfa sem Heimavellir hf. eða dótturfélög eru útgefandi að.Búið er að greiða fyrstu greiðsluna og gert er ráð fyrir að viðskiptunum verði lokið fyrir 10. september 2020.Frekari upplýsingar veitir Arnar Gauti Reynisson, framkvæmdastjóris: 860-5300
AQUA BIO TECHNOLOGY ASA: RESOLUTIONS TO INCREASE THE SHARE CAPITAL – FURTHER INFORMATION ABOUT THE SUBSEQUENT OFFERING
Written by Customer Service on . Posted in Public Companies.
Reference is made to the stock exchange notices announced on 18 August 2020 regarding the successful placing of a private placement with gross proceeds of NOK 10.5 million (the “Private Placement“) and a private placement with gross proceeds of NOK 2.13 million (the “Private Placement II“). In order to reduce the dilutive effect of the Private Placement and the Private Placement II, the Board of Directors of Aqua Bio Technology ASA (“ABT” or the “Company“) also decided to initiate a subsequent offering of new shares towards eligible shareholders (the “Subsequent Offering“).The Board of Directors has today resolved share capital increases in connection with the Private Placement II and the Subsequent Offering, as further detailed below.In connection with the Private Placement...
AQUA BIO TECHNOLOGY ASA: VEDTAK OM Å ØKE AKSJEKAPITALEN – NÆRMERE INFORMASJON OM DEN ETTERFØLGENDE EMISJONEN
Written by Customer Service on . Posted in Public Companies.
Det vises til børsmeldingene 18. august 2020 angående vellykket plassering av en rettet emisjon med bruttoproveny på NOK 10,5 millioner (den “Rettede Emisjonen“) og en rettet emisjon med bruttoproveny på NOK 2,13 million (den ” Rettede Emisjonen II“). For å redusere den utvannende effekten av den Rettede Emisjonen og den Rettede Emisjonen II, har Styret i Aqua Bio Technology ASA (“ABT” eller “Selskapet“) også bestemt å iverksette en etterfølgende emisjon overfor kvalifiserte aksjeeiere (den “Etterfølgende Emisjonen“).Styret har i dag vedtatt kapitalforhøyelser i forbindelse med den Rettede Emisjonen II og den Etterfølgende Emisjonen, som nærmere beskrevet nedenfor.I forbindelse med den Rettede Emisjonen II, har Styret vedtatt å øke aksjekapitalen med NOK 1 065 000 ved utstedelse...
Sbanken ASA:
Written by Customer Service on . Posted in Public Companies.
Sbanken ASA has today issued a new Additional Tier 1 bond of NOK 100 million, with a coupon equal to 3 months Nibor + 3.00 percentage points. The Additional Tier 1 bond issue has a perpetual tenor, with a first call option after 5 years.Sbanken ASA has in addition issued NOK 150 million in a new dated Tier 2 bond issue with a coupon equal to 3 months Nibor + 1.25 percentage points. The Tier 2 issue has a tenor of 10 years, with a first call option after 5 years.The two bond issues will sought to be listed on Nordic ABM and the issue dates will be 28 August 2020.Sbanken ASA has in conjunction with the bond issues, with settlement date 28 August 2020, bought back NOK 29 million of ISIN NO0010746456 (SBANK03 PRO) at a price of 100.515 per cent and NOK 16 million of ISIN NO0010746464 (SBANK04 PRO) at a price of 100.271 per cent.Sbanken ASA’s...
Sbanken ASA: Vellykket utstedelse av fondsobligasjon og ansvarlig lån og tilbakekjøp
Written by Customer Service on . Posted in Public Companies.
Sbanken ASA har i dag utstedt et nytt fondsobligasjonslån på NOK 100 millioner, med kupong 3 måneders Nibor + 3,00 prosentpoeng. Fondsobligasjonslånet er evigvarende, med første innløsningsrett etter 5 år.Sbanken ASA har i tillegg utstedt et nytt tidsbegrenset ansvarlig obligasjonslån på NOK 150 millioner, med kupong 3 måneders Nibor + 1,25 prosentpoeng. Det ansvarlige lånet har en løpetid på 10 år med første innløsningsrett etter 5 år.De to obligasjonslånene vil søkes notert på Nordic ABM og emisjonsdato er satt til 28. august 2020.Sbanken ASA har i forbindelse med utstedelsene, med oppgjørsdato 28. august 2020, kjøpt tilbake NOK 29 millioner av ISIN NO0010746456 (SBANK03 PRO) til kurs 100,515 prosent og NOK 16 millioner av ISIN NO0010746464 (SBANK04 PRO) til kurs 100,271 prosent.Styret i Sbanken ASA har godkjent låneopptakene og tilbakekjøpene....
Surna Introduces Expanded Services and Technology Offerings
Written by Customer Service on . Posted in Public Companies.
Announces Full MEP Design Services with Expansion of HVAC TechnologiesBoulder, Colorado, Aug. 25, 2020 (GLOBE NEWSWIRE) — Surna Inc. (OTCQB: SRNA) today announced an expansion of its portfolio of services and products.While Surna has been historically known for its expertise in 2 and 4-pipe chilled water solutions (also known as hydronic cooling and dehumidification), its new technology offerings include:Direct expansion (DX) units with standalone dehumidification options, including split systems, mini-splits and packaged roof top units (RTUs). Complex DX system options with integrated dehumidification via hot gas reheat and wintertime economization. Desiccant solutions for low humidity applications. Racking solutions for optimal airflow designs in tiered layouts.Many clients have already benefited from Surna’s expanded MEP (mechanical,...
Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19
Written by Customer Service on . Posted in Public Companies.
– The INSPIRE Trial is a Randomized, Placebo-Controlled, Multi-Center Study Evaluating the Safety and Efficacy of Intravenous Infusion of CAP-1002 –– The Study Leverages Capricor’s Lead Asset, CAP-1002 Technology –LOS ANGELES, Aug. 25, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for a Phase 2 clinical trial of CAP-1002 in patients with COVID-19. The study will enroll patients who have a confirmed diagnosis of SARS-CoV-2 and require supplemental oxygen. Enrollment is expected to commence shortly.The INSPIRE trial...
Veritas Farms, Inc. (OTCQB:VFRM) Reports Financial Results for Quarter and Six Months Ended June 30, 2020
Written by Customer Service on . Posted in Public Companies.
Fort Lauderdale, FL, Aug. 25, 2020 (GLOBE NEWSWIRE) —via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that the Company has reported its operating results for the quarter and six months ended June 30, 2020, through the filing of its Quarterly Report on Form 10-Q with the SEC. The report, as well as the Company’s other periodic filings with the SEC, may be viewed at www.sec.gov.Selected Financial Highlights – Six Months Ended June 30, 2020, and Quarter Ended June 30, 2020Total Revenue of $3,363,699 in 2020 vs $4,496,275 in 2019Total Revenue of $2,209,388 in Q2-2020 vs $2,971,345 in Q2-2019Tripled e-commerce revenue in Q2 2020 vs...